Explore the latest developments concerning Rare eye disorder.
Rare eye disorder linked to Ozempic-like medications
The TGA has issued a safety warning for people taking GLP-1-based drugs such as Ozempic and Wegovy. (Reuters: Hollie Adams)
The Therapeutic Goods Administration is warning of a rare but serious eye disorder that could be caused by GLP-1-based drugs.
It says people taking these drugs should be alert to any vision loss and seek urgent medical attention if they notice any changes.
The association for optometrists says patients should not be unnecessarily alarmed and can continue using the medications if they have no symptoms.
The medicines regulator has issued a new safety warning for GLP-1-based drugs, like Ozempic, which could potentially cause a rare but serious eye disorder.
Australia news live: Socceroos star allegedly tests positive for cocaine; Barnaby Joyce’s wife bans ABC’s 7.30 from farm
Get our breaking news email, free app or daily news podcast
Millions of Australians living with chronic pain are fighting an invisible battle that extends far beyond health care.
Itâs a condition that forces many to leave the workforce, with fresh research revealing that 42% of sufferers have had to stop working due to chronic pain, AAP reports.
The 2026 National Pain Report also revealed that 57% of respondents reported their conditions had affected their ability to work.
double quotation markI felt like I couldnât disclose my chronic pain to any employer, there were times I was in a pain zone and I had to go home and I was definitely met with a lot of shame.
16A Human Hair Bundles 28 30 32 34Inch straight Bundles Human Hair 100% Unprocessed Brazilian Virgin Hair 3/4/5 Bundles Deals
TGA issues new warning after finding link between GLP-1 medicines Ozempic, Wegovy, Mounjaro to eye disorder
Australia’s medicine regulator has issued a safety warning over popular weight-loss drugs like Ozempic, saying they could cause a rare vision disorder.
The Therapeutic Goods Administration warned the GLP-1 RA class of medicines have the potential to cause a rare, but severe, form of eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION).
The disorder may result in permanent visual impairment, including blindness. There is currently no treatment for it.
The TGA urges any patients who experience sudden vision loss, even if only partial, should seek urgent medical attention.
The regulator revealed a potential link between GLP-1 RAs and NAION was first discovered in July 2024 following a JAMA Ophthalmology study.
For more detailed information, explore updates concerning Rare eye disorder.
